304 related articles for article (PubMed ID: 19167488)
1. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation.
Graf A; Rades T; Hook SM
Eur J Pharm Sci; 2009 Apr; 37(1):53-61. PubMed ID: 19167488
[TBL] [Abstract][Full Text] [Related]
2. Protein delivery using nanoparticles based on microemulsions with different structure-types.
Graf A; Jack KS; Whittaker AK; Hook SM; Rades T
Eur J Pharm Sci; 2008 Apr; 33(4-5):434-44. PubMed ID: 18329862
[TBL] [Abstract][Full Text] [Related]
3. Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.
Liang M; Davies NM; Toth I
Int J Pharm; 2008 Oct; 362(1-2):141-6. PubMed ID: 18598746
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
5. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides.
Graf A; Ablinger E; Peters S; Zimmer A; Hook S; Rades T
Int J Pharm; 2008 Feb; 350(1-2):351-60. PubMed ID: 17923347
[TBL] [Abstract][Full Text] [Related]
6. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
Sharma G; Wilson K; van der Walle CF; Sattar N; Petrie JR; Ravi Kumar MN
Eur J Pharm Biopharm; 2010 Oct; 76(2):159-69. PubMed ID: 20655382
[TBL] [Abstract][Full Text] [Related]
7. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.
Watnasirichaikul S; Rades T; Tucker IG; Davies NM
J Pharm Pharmacol; 2002 Apr; 54(4):473-80. PubMed ID: 11999123
[TBL] [Abstract][Full Text] [Related]
8. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.
Krauel K; Davies NM; Hook S; Rades T
J Control Release; 2005 Aug; 106(1-2):76-87. PubMed ID: 15967536
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
11. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
[TBL] [Abstract][Full Text] [Related]
12. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
Cilek A; Celebi N; Tirnaksiz F; Tay A
Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411
[TBL] [Abstract][Full Text] [Related]
13. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
Damgé C; Maincent P; Ubrich N
J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
[TBL] [Abstract][Full Text] [Related]
15. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
16. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
17. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
18. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
